Skopos Labs, Inc. Liva Nova PLC Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Liva Nova PLC stock. As of the latest transaction made, Skopos Labs, Inc. holds 51 shares of LIVN stock, worth $2,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51Holding current value
$2,226% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LIVN
# of Institutions
266Shares Held
55.2MCall Options Held
72.5KPut Options Held
65.6K-
Black Rock Inc. New York, NY6.9MShares$301 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.61MShares$201 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$116 Million0.0% of portfolio
-
State Street Corp Boston, MA2.1MShares$91.6 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA2.08MShares$90.7 Million0.02% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.34B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...